ELIZABETH ROMANO: Open Payments
NPI 1487321345 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 66 payments from 30 companies in 2025. Trend: 2023 $782 · 2024 $1,561 · 2025 $1,607
Food & beverage: $1,429Education: $178
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $229 |
| Daiichi Sankyo Inc. | 7 | $190 |
| AstraZeneca Pharmaceuticals LP | 7 | $176 |
| Alexion Pharmaceuticals, Inc. | 2 | $125 |
| Janssen Biotech, Inc. | 3 | $112 |
| Merck Sharp & Dohme LLC | 2 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| ABBVIE INC. | 2 | $53 |
| Eisai Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 3 | $48 |
Products named: KISQALI, Enhertu, RYBREVANT, SOLIRIS, DATROWAY, KEYTRUDA, OPDIVO, Venclexta.
Industry payments across IN — which companies pay providers there.
